Skyler Jackman, Ph.D., assistant scientist at the OHSU Vollum Institute, is the senior author of a neurotransmitter discovery that is published in the journal Nature. He is sitting next to the scope used to view synaptic transmission. Credit: OHSU/Christine Torres Hicks
Scientists created “knock-out” mice that lacked the SYT3 gene. They discovered that in contrast to control mice that had the gene, those mice lacked the more robust level of synaptic transmission.
Notably, SYT3 gene mutations have been linked to human instances of <span class="glossaryLink" aria-describedby="tt" data-cmtooltip="
” data-gt-translate-attributes='[{“attribute”:”data-cmtooltip”, “format”:”html”}]’>autism spectrum disorder and epilepsy. According to Jackman, recent research raises the prospect of developing gene therapies or pharmaceutical approaches that target SYT3.
“Imbalances in neurotransmitter release are the underlying causes for many neurological disorders,” said lead author Dennis Weingarten, Ph.D., a postdoctoral researcher in the Jackman lab. In the future, he said, “understanding these molecular switches — such as SYT3 — is a crucial step for us to combat these diseases.”
Jackman’s lab specializes in the study of synaptic transmission. The human brain contains hundreds of trillions of synapses. Discovering the molecules that endow these specialized structures with their unique properties is essential for understanding brain function and neurological disorders.
“Synaptic transmission is fundamental for sensing our surroundings, making decisions, and nearly every other feature of our inner world,” Jackman said.
Reference: “Fast resupply of synaptic vesicles requires synaptotagmin-3” by Dennis J. Weingarten, Amita Shrestha, Kessa Juda-Nelson, Sarah A. Kissiwaa, Evan Spruston, and Skyler L. Jackman, 19 October 2022, Nature.
DOI: 10.1038/s41586-022-05337-1
The study was funded by the Whitehall Foundation, the Medical Research Foundation, and the National Institutes of Health Imaging Core Facility.
